Relmada Therapeutics Inc
F:4E2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relmada Therapeutics Inc
F:4E2
|
US |
Shareholder Yield
Current shareholder yield for
Relmada Therapeutics Inc is
.
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Relmada Therapeutics Inc
| Average Annual Return | -44.29% |
| Standard Deviation of Annual Returns | 61.12% |
| Max Drawdown | -97% |
| Market Capitalization | 672.3m EUR |
| Shares Outstanding | 30 099 200 |
| Percentage of Shares Shorted |
N/A
|